Key Highlights
- Domo delivered Q4 earnings per share of $0.03, surpassing the -$0.03 consensus by $0.06
- Quarterly revenue reached $79.63M, exceeding analyst expectations of $78.65M
- Shares currently trade at $4.38, plunging 74% in the last six months, hovering near the 12-month floor of $3.45
- Citizens maintained its Market Underperform stance with a $3.50 target, highlighting leverage and competitive headwinds
- The company holds approximately $126M in debt at a 12.2% interest rate against just $43M in cash reserves
Domo delivered an unexpected profitable quarter in its fiscal 2026 Q4, defying Wall Street projections. The business intelligence platform provider reported earnings of $0.03 per share versus the anticipated $0.03 loss — representing a six-cent positive variance.
Domo $DOMO +36.7% After-Hours on big earnings beat:
Rev $79.63m v est $78.62m
Adj EPS $0.03 v est -$0.03 (big beat)
Adj Operating Income: $8.13m v est $3.86m
Operating Margin -13.3%, up from -15.6% same quarter last year Billings $111.2m, up 8.4% y/y https://t.co/3meeFaqOhQ pic.twitter.com/n5WrKveG7f— Traders Community (@TradersCom) March 11, 2026
Quarterly revenue totaled $79.63 million, outperforming the $78.65 million consensus. The company achieved beats across both fundamental metrics.
Shares climbed $0.11 during the session to $4.38, with trading volume reaching approximately 1.75 million shares — surpassing the typical 1.27 million average. However, the broader trend paints a concerning picture.
The stock has plummeted roughly 74% across the previous six months. Its 12-month peak stands at $18.49. Shares currently languish beneath both the 50-day moving average of $5.68 and the 200-day moving average of $10.47.
Even with the earnings outperformance, Citizens maintained its Market Underperform designation alongside a $3.50 price objective on the stock. This target sits underneath the current trading level.
Leverage Remains Primary Risk Factor
Citizens emphasized Domo’s debt burden as a significant concern. The firm maintains a credit facility totaling approximately $126 million with a 12.2% interest rate, maturing in August 2028. This compares unfavorably to the company’s modest $43 million cash position.
This creates a current ratio of 0.57 — indicating that near-term liabilities surpass readily available assets. The financial position is constrained.
The credit agreement includes restrictive covenants. Domo must achieve minimum annual recurring revenue of $285 million by fiscal Q4 2026 end, escalating to $290 million by fiscal Q1 2027 conclusion. Additionally, the company needs to sustain adjusted EBITDA of no less than $12.1 million and $15.2 million at these respective milestones.
A liquidity provision mandates Domo maintain a minimum of $25 million in unrestricted cash within U.S.-based pledged accounts.
Competitive Landscape Intensifies
Citizens also highlighted the challenging competitive arena. Domo functions within the Snowflake ecosystem, encountering pressure from rivals such as Sigma Computing.
Sigma revealed at last week’s Citizens Technology Conference that it achieved $200 million in annual recurring revenue — essentially doubling on a year-over-year basis. Such growth trajectories underscore the intensifying competitive pressures.
Wall Street opinion on Domo remains divided. TD Cowen reduced its target from $16 down to $9 while maintaining a Buy rating. Citigroup downgraded the stock from Outperform to Underperform in February. Lake Street and Wall Street Zen both shifted to Hold ratings.
Cantor Fitzgerald represents the exception, preserving an Overweight rating alongside a $22 price target.
The aggregate consensus registers as “Hold” with a $12.07 price target — approximately triple the current share price.
Regarding ownership structure, institutional investors control 76.64% of outstanding shares. Goldman Sachs expanded its stake by 22.5% during the most recent quarter. AQR Capital Management boosted its holdings by 17.5%.
The company carries a market capitalization of $183 million, a P/E ratio of -2.56, and a beta coefficient of 1.70. Its 12-month trough stands at $3.45.





